|
KIAA0391 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.834000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.807600E-02 |
| Normal-vs-Stage2 |
7.676400E-01 |
| Normal-vs-Stage3 |
5.494300E-02 |
| Normal-vs-Stage4 |
8.587700E-04 |
| Stage1-vs-Stage2 |
1.050950E-01 |
| Stage1-vs-Stage3 |
8.557000E-01 |
| Stage1-vs-Stage4 |
3.162300E-02 |
| Stage2-vs-Stage3 |
1.061850E-01 |
| Stage2-vs-Stage4 |
5.739400E-03 |
| Stage3-vs-Stage4 |
7.039600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.495500E-02 |
| Normal-vs-AfricanAmerican |
4.065000E-01 |
| Normal-vs-Asian |
9.492200E-02 |
| Caucasian-vs-AfricanAmerican |
5.986000E-01 |
| Caucasian-vs-Asian |
8.029200E-01 |
| AfricanAmerican-vs-Asian |
5.384400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.998500E-03 |
| Normal-vs-Female |
7.535800E-02 |
| Male-vs-Female |
1.260630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.658000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.144460E-02 |
| Normal-vs-Age(61-80Yrs) |
6.144200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.971200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.502400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.450420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.077000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.240300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.766400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.500200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.547400E-01 |
| Classical-VS-Follicular |
4.083700E-02 |
| Classical-VS-Other |
2.434800E-01 |
| Classical-VS-Normal |
1.453520E-02 |
| Tall-VS-Follicular |
1.820790E-01 |
| Tall-VS-Other |
3.111600E-01 |
| Tall-VS-Normal |
8.527900E-02 |
| Follicular-VS-Other |
1.827750E-02 |
| Follicular-VS-Normal |
9.656800E-01 |
| Other-VS-Normal |
1.784070E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.102570E-01 |
| Normal-vs-N1 |
4.613500E-04 |
| N0-vs-N1 |
8.375500E-03 |
|
|
